SCHEMBL31080100

SCHEMBL31080100

C[C@H]1CN(C(=O)OC(C)(C)C)CCC[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
KMT2A Q03164 1/20 0.53
HPGD P15428 1/20 0.51
EPHX1 P07099 1/20 0.46
USP2 O75604 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PREP P48147 2/20 0.43
USP30 Q70CQ3 1/20 0.43
HPGDS O60760 1/20 0.42
RECQL P46063 1/20 0.42
NR1H2 P55055 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
GLS O94925 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31080706 1.00 MEN1 (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL31080739 1.00 MEN1 (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL31080723 1.00 MEN1 (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL31080651 1.00 MEN1 (0.53) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL17286034 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL2924321 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL2904961 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL30521367 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL1549896 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD
SCHEMBL2924319 0.90 HPGD (0.50) MEN1ALDH1A1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695238-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2026-02-18 EP disclosed
WO-2024216154-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2024-10-17 WO disclosed